|
1.
|
Yang T, McNally BA, Ferrone S, Liu Y and
Zheng P: A single-nucleotide deletion leads to rapid degradation of
TAP-1 mRNA in a melanoma cell line. J Biol Chem. 278:15291–15296.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Vujanovic L, Whiteside TL, Potter DM, Chu
J, Ferrone S and Butterfield LH: Regulation of antigen presentation
machinery in human dendritic cells by recombinant adenovirus.
Cancer Immunol Immunother. 58:121–133. 2009. View Article : Google Scholar
|
|
3.
|
Young LS and Rickinson AB: Epstein-Barr
virus: 40 years on. Nat Rev Cancer. 4:757–768. 2004.
|
|
4.
|
Gallicchio L, Matanoski G, Tao XG, et al:
Adulthood consumption of preserved and nonpreserved vegetables and
the risk of nasopharyngeal carcinoma: a systematic review. Int J
Cancer. 119:1125–1135. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Bei JX, Jia WH and Zeng YX: Familial and
large-scale case-control studies identify genes associated with
nasopharyngeal carcinoma. Semin Cancer Biol. 22:96–106. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Jia WH and Qin HD: Non-viral environmental
risk factors for nasopharyngeal carcinoma: a systematic review.
Semin Cancer Biol. 22:117–126. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Shao JY, Zhang Y, Li YH, et al: Comparison
of Epstein-Barr virus DNA level in plasma, peripheral blood cell
and tumor tissue in nasopharyngeal carcinoma. Anticancer Res.
24:4059–4066. 2004.
|
|
8.
|
Chan AT, Lo YM, Zee B, et al: Plasma
Epstein-Barr virus DNA and residual disease after radiotherapy for
undifferentiated nasopharyngeal carcinoma. J Natl Cancer Inst.
94:1614–1619. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Bar-Sela G, Kuten A, Minkov I, Gov-Ari E
and Ben-Izhak O: Prevalence and relevance of EBV latency in
nasopharyngeal carcinoma in Israel. J Clin Pathol. 57:290–293.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Raab-Traub N: Epstein-Barr virus in the
pathogenesis of NPC. Semin Cancer Biol. 12:431–441. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Horikawa T, Yoshizaki T, Kondo S, Furukawa
M, Kaizaki Y and Pagano JS: Epstein-Barr virus latent membrane
protein 1 induces Snail and epithelial-mesenchymal transition in
metastatic nasopharyngeal carcinoma. Br J Cancer. 104:1160–1167.
2011. View Article : Google Scholar
|
|
12.
|
Li W, Deng XM, Wang CX, et al:
Down-regulation of HLA class I antigen in human papillomavirus type
16 E7 expressing HaCaT cells: correlate with TAP-1 expression. Int
J Gynecol Cancer. 20:227–232. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Li XL, Zhang D, Knight D, et al: Priming
of immune responses against transporter associated with antigen
processing (TAP)-deficient tumours: tumour direct priming.
Immunology. 128:420–428. 2009. View Article : Google Scholar
|
|
14.
|
Everett MW and Edidin M: Tapasin increases
efficiency of MHC I assembly in the endoplasmic reticulum but does
not affect MHC I stability at the cell surface. J Immunol.
179:7646–7652. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Tourkova IL, Shurin GV, Ferrone S and
Shurin MR: Interferon regulatory factor 8 mediates tumor-induced
inhibition of antigen processing and presentation by dendritic
cells. Cancer Immunol Immunother. 58:567–574. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Singal DP, Ye M and Bienzle D:
Transfection of TAP 1 gene restores HLA class I expression in human
small-cell lung carcinoma. Int J Cancer. 75:112–116. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Wang X, Ni J, Hsu CL, et al: Reduced
expression of tocopherol-associated protein (TAP/Sec14L2) in human
breast cancer. Cancer Invest. 27:971–977. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Lopez-Albaitero A, Nayak JV, Ogino T, et
al: Role of antigen-processing machinery in the in vitro resistance
of squamous cell carcinoma of the head and neck cells to
recognition by CTL. J Immunol. 176:3402–3409. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Facoetti A, Nano R, Zelini P, et al: Human
leukocyte antigen and antigen processing machinery component
defects in astrocytic tumors. Clin Cancer Res. 11:8304–8311. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Tanaka K, Tsuchikawa T, Miyamoto M, et al:
Down-regulation of human leukocyte antigen class I heavy chain in
tumors is associated with a poor prognosis in advanced esophageal
cancer patients. Int J Oncol. 40:965–974. 2012.PubMed/NCBI
|
|
21.
|
Cresswell AC, Sisley K, Laws D, Parsons
MA, Rennie IG and Murray AK: Reduced expression of TAP-1 and TAP-2
in posterior uveal melanoma is associated with progression to
meta-static disease. Melanoma Res. 11:275–281. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Seliger B, Atkins D, Bock M, et al:
Characterization of human lymphocyte antigen class I
antigen-processing machinery defects in renal cell carcinoma
lesions with special emphasis on transporter-associated with
antigen-processing down-regulation. Clin Cancer Res. 9:1721–1727.
2003.
|
|
23.
|
Han LY, Fletcher MS, Urbauer DL, et al:
HLA class I antigen processing machinery component expression and
intratumoral T-cell infiltrate as independent prognostic markers in
ovarian carcinoma. Clin Cancer Res. 14:3372–3379. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Liu Q, Hao C, Su P and Shi J:
Down-regulation of HLA class I antigen-processing machinery
components in esophageal squamous cell carcinomas: association with
disease progression. Scand J Gastroenterol. 44:960–969. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Moss DJ, Khanna R, Sherritt M, Elliott SL
and Burrows SR: Developing immunotherapeutic strategies for the
control of Epstein-Barr virus-associated malignancies. J Acquir
Immune Defic Syndr. 1:S80–S83. 1999.PubMed/NCBI
|
|
26.
|
Chua ML, Ong SC, Wee JT, et al: Comparison
of 4 modalities for distant metastasis staging in endemic
nasopharyngeal carcinoma. Head Neck. 31:346–354. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Wang CT, Cao KJ, Li Y, Xie GF and Huang
PY: Prognosis analysis of nasopharyngeal carcinoma patients with
distant metastasis. Chin J Cancer. 26:212–215. 2007.(In
Chinese).
|
|
28.
|
Fang FM, Tsai WL, Chien CY, et al:
Pretreatment quality of life as a predictor of distant metastasis
and survival for patients with nasopharyngeal carcinoma. J Clin
Oncol. 28:4384–4389. 2010. View Article : Google Scholar : PubMed/NCBI
|
